Iovance Biotherapeutics, Inc.
IOVA
Revenue
73.69M
▲15.14M▲25.85%
3 Months ChangeAssets
910.43M
▼-80.69M▼-8.14%
3 Months ChangeLiabilities
200.02M
▼-17.64M▼-8.10%
3 Months ChangeFree Cash Flow
-126.45M
▼-20.97M▼-19.88%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-09
Form 8-K
ID: 0001104659-24-087876
2024-08-08
Form 10-Q
ID: 0001558370-24-011641
2024-08-08
Form 8-K
ID: 0001104659-24-087259
2024-06-28
Form 8-K
ID: 0001104659-24-075997
2024-06-11
Form 8-K
ID: 0001104659-24-070470
2024-06-03
Form 8-K
ID: 0001104659-24-067485
2024-05-24
Form 8-K
ID: 0001104659-24-064825
2024-05-09
Form 10-Q
ID: 0001558370-24-007646
2024-05-09
Form 8-K
ID: 0001104659-24-059322
2024-04-03
Form 8-K
ID: 0001104659-24-043158